The outcome of this litigation as well as the effects of the IRA on our business and the healthcare industry in general are not yet known.
All entries for: Auro Biosciences, Inc
March 30, 2026
Auro Biosciences, Inc
Neutral Outlook
Boston, MA
1-50 employees
Disease Area: Oncology
Drug Type: Biologic